Talk:Alnylam Pharmaceuticals

This article is rated Start-class on Wikipedia's content assessment scale.
It is of interest to the following WikiProjects:

United States: Massachusetts / Boston Low‑importance

	United States portal This article is within the scope of WikiProject United States, a collaborative effort to improve the coverage of topics relating to the United States of America on Wikipedia. If you would like to participate, please visit the project page, where you can join the ongoing discussions. Template Usage Articles Requested! Become a Member Project Talk Alerts United StatesWikipedia:WikiProject United StatesTemplate:WikiProject United StatesUnited States articles
Low	This article has been rated as Low-importance on the project's importance scale.
	Massachusetts portal This article is supported by WikiProject Massachusetts (assessed as Low-importance).
	Massachusetts portal This article is supported by WikiProject Massachusetts - Boston (assessed as Low-importance).

Companies Low‑importance

This article is within the scope of WikiProject Companies, a collaborative effort to improve the coverage of companies on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.CompaniesWikipedia:WikiProject CompaniesTemplate:WikiProject Companiescompany articles

Low This article has been rated as Low-importance on the project's importance scale.

WikiProject Companies To-do:

Here are some tasks awaiting attention:

Article requests : Wikipedia:Requested articles/Business and economics/Companies
Assess : Category:Unassessed company articles
Copyedit : Category:Company articles needing attention
Infobox : Category:Company articles needing infoboxes
Maintain : Portal:Companies
Stubs : Help expand stub articles located at Category:Company stubs
Other :
- Tag company articles with the {{portal|Companies}} template
- Tag company talk pages with the {{WikiProject Companies}} project banner
- Answer requests for comments

Edits of this day

Fixed location of infobox. Removed close association tag, because the article has not been updated to any significant extent, in that manner, in a couple of years.

However, the article is in awful shape (dated, incomplete, and still somewhat news-release-like), so other text was added, and other tags place. Please discuss here before removing, unless they clearly are in error with regard to the specific matter raised.

Moved the following primary sources to Talk,^[1]^[2]^[3] so that secondary sources can be added, and when added can be in proper format, not inappropriate (as in 3, which requires WP:OR) or primary sources (as in 1 and 2), and sloppy like these.

^ "Potent and specific genetic interference by double stranded RNA in Caenorhabditis elegans". FIRE, A.; XU, S.; MONTGOMERY, M.K.; KOSTAS, S.A.; DRIVER, S.E. and MELLO, C.C. , Nature, 1998, vol. 391, no. 6669, p. 806-811.
^ "Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells" ELBASHIR, S.M., HARBORTH, J., LENDECKEL, W., YALCIN, A., WEBER, K. & TUSCHL, T. (2001). Nature 2001, vol 411, pp: 494-8.
^ "ALAS1 aminolevulinate, delta-, synthase 1 [ Homo sapiens (human) ]". National Center for Biotechnology Information. Retrieved 4 September 2013.

Le Prof 02:28, 11 December 2015 (UTC)

[1] "Potent and specific genetic interference by double stranded RNA in Caenorhabditis elegans". FIRE, A.; XU, S.; MONTGOMERY, M.K.; KOSTAS, S.A.; DRIVER, S.E. and MELLO, C.C. , Nature, 1998, vol. 391, no. 6669, p. 806-811.

[2] "Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells" ELBASHIR, S.M., HARBORTH, J., LENDECKEL, W., YALCIN, A., WEBER, K. & TUSCHL, T. (2001). Nature 2001, vol 411, pp: 494-8.

[3] "ALAS1 aminolevulinate, delta-, synthase 1 [ Homo sapiens (human) ]". National Center for Biotechnology Information. Retrieved 4 September 2013.

[1]

[2]

[3]

Talk:Alnylam Pharmaceuticals

Edits of this day

Navigation menu

Search